Psychological issues in cancer genetics: Current research and future priorities

Patient Education and Counseling

Volumn 32, Issue 1-2, 1997, Pages 19-31

  Hopwood, Penelope ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Counselling; Familial cancer; Psychosocial

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER RESEARCH; CANCER SCREENING; COPING BEHAVIOR; EMOTIONAL STRESS; FAMILIAL CANCER; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MASTECTOMY; MENTAL STRESS; PRIORITY JOURNAL;

ATTITUDE TO HEALTH; FORECASTING; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; RESEARCH;

EID: 0030827010     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(97)00060-8     Document Type: Article

References (70)

1. Birch J.M. Germline mutations in the P53 tumour suppressor gene: scientific, clinical and ethical challenges. Br J Cancer. 66:1992;424-426.
2. Eeles R.A. Predictive testing for germline mutations in the P53 gene: are all the questions answered? Eur J.Cancer. 29A:1993;1361-1365.
3. Eng L., Stratton M., Ponder B., Murday V., Easton D., Sacks N., Watson M., Eeles R. Familial cancer syndrome. Lancet. 343:1994;709-713.
4. Easton D.F., Ford D., Bishop D.T., The Breast Cancer Linkage Consortium Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet. 56:1995;265-271.
5. Claus E.B., Risch N.J., Thompson W.D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 48:1991;232-242.
6. Ford D., Euston D.P., Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 57:1995;1457-1462.
7. Miki Y., Swensen J., Shattuck-Eidens D., Futreal A., Harshmank, Tavtigianset al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
8. Wooster R., Neuhausen S., Mangion J., Quirk Y., Ford D., Collins N.et al. Localisation of a breast cancer susceptibility gene, BRCA2 to chromosome 13Q 12-13. Science. 265:1994;2088-2090.
9. Mackey S.E., Creasman W.T. Ovarian cancer screening. J Clin Oncol. 13:1995;783-793.
10. Fletcher S.W., Black W., Harris R.et al. Report of the International Workshop on screening for breast cancer. J Natl Cancer Inst. 85:1993;1644-1656.
11. Swift M.L., Reitnauer P.J., Morrell D., Chase C.L. Breast and other cancers in families with ataxia telanglectasia. N Engl J Med. 316:1987;1289-1294.
12. Easton DF, Bishop DT, Ford D, Crockford CP, The Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 24 families. Am J Hum Genet 1993;52:678-701.
13. Lynch H.T., Watson P., Lynch J.F. Epidemiology and risk factors. Clin Obstet Gynaecol. 32:1989;750-760.
14. Gail M.H., Brunton L.A., Byar D.P., Corle D.R., Green S.B., Scheliver C.et al. Protecting individualised probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 81:1989;1879-1916.
15. Anderson D.E., Badzioch M.D. Combined effect of family history and reproductive factors in breast cancer risk. Cancer. 63:1989;349-353.
16. Parazzani F., La Vecchia C., Negri E., Franchesci S., Bocciolane L. Menstrual and reproductive factors and breast cancer in women with a family history of the disease. Int J Cancer. 51:1992;677-681.
17. Lynch H.T., Albano W.A., Layton M.A., Kimberling W.V., Lynch J.F. Breast cancer, genetics and age at first pregnancy. J Med Genet. 21:1994;96-98.
18. Olsson H., Moller T.R., Ranstam J. Early oral contraceptive use and pre-menopausal breast cancer - final report from a study in Southern Sweden. J Natl Cancer Inst. 81:1989;1000-1004.
19. Black M.M., Barclay T.H.C., Polednak A., Kwoh C.S., Leis H.P., Piluk S. Family history, oral contraceptive usage and breast cancer. Cancer. 51:1983;2197-2251.
20. Lerman C., Daly M., Masny A., Balshean A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 12:1994;843-850.
21. Klijn J.G., Devilee P., Van-Geel A.N., Tilanus-Linthorst M.M., Dudok-d-Wit C., Meijers-Heijboer E.J. Initial Dutch results with presymptomatic DNA tests in familial breast/ovarian carcinoma. Ned-Tijdschr Geneeskd. 139:1995;439-445.
22. Markel D.S., Young A.B., Penney J.B. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington Disease in Michigan. Am J Med Genet. 27:1987;295-305.
23. Kessler S., Field T., Worth L., Masbarger A. Attitudes of persons at risk for Huntington Disease toward predictive testing. Am J Med Genet. 26:1987;259-270.
24. Craufurd D., Dodge A., Kerzil-Storrar L. Uptake of presymptomatic predictive testing for Huntingdon's disease. Lancet. 2:1991;603-605.
25. Quaid K.A., Brandt J., Faden R.R., Folstein S.G. Knowledge, attitude and the decision to be tested for Huntington's disease. Clin Genet. 36:1989;431-438.
26. Watson M, Murday V, Lloyd S, Porter B, Averill D, Eeeles R. Genetic testing in breast/ovarian cancer (BRCA1) families. Lancet 1995;346:583 (letter).
27. Houlston R.S., Murday V., Harocopos C., Williams C.B., Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family history clinic. Br Med J. 391:1990;366-368.
28. Bloch M., Adams S., Huggins M., Hayden M.R. Predictive testing for Huntingdon disease in Canada: The experience of those receiving an increased risk. Am J Med Genet. 42:1992;499-507.
29. Huggins M., Bloch M., Wiggins S., Adams S., Suchowersky O., Trew M., Elimek M., Greenberg C.R., Elefl M., Thompson L.P.et al. Predictive testing for Huntington Disease in Canada: adverse effects and un-expected results in those receiving a decreased risk. Am J Med Genet. 42:1992;508-515.
30. Chapman M.A. Canandian experience with predictive testing for Huntington's disease: Lessons for genetic testing centres and policy makers. Am J Med Genet. 42:1992;491-498.
31. Lerman C., Andrain J., Croyle R.T. DNA testing for meritable breast cancer risks: Lessons from traditional genetic counselling. Ann Behav Med. 16:1994;327-333.
32. Allen W., Ostret H. Anticipating unfair uses of genetic information. Am J Hum Genet. 16:1993;327-333.
33. Harper PS. Research samples from families with genetic diseases: a proposed code of conduct. Br Med J 1993;306:1391-4 (editorial).
34. Kessler S. Invited essay on the psychological aspects of genetic counselling v preselection: A family coping strategy in Huntingdon disease. Am J Med Genet. 31:1988;617-621.
35. Guidelines for predictive testing for Huntingdon's disease. New York: The Huntington's Disease Society of America, 1989.
36. Lynch H.T., Watson P., Conway T.A.et al. DNA screening for breast/ovarian cancer susceptibility based on linked makers: A family study. Arch Int Med. 153:1993;1979-1987.
37. Lerman C., Croyle R. Psychologic issues in genetic screening for breast cancer susceptibility. Arch Int Med. 154:1994;609-616.
38. Polednak A.P., Lane D.S., Burg M.A. Risk perception, family history use of breast cancer screening tests. Cancer Detect Prev. 15:1991;257-263.
39. Stefanek M.E., Wilcox P. First degree relatives of breast cancer patients: screening practices and provision of risk information. Cancer Detect Prev. 15:1991;379-384.
40. Kash K.M., Holland J.C., Halper M.S., Miller D.M. Psychological distress and surveillance behaviours of women with a family history of breast cancer. J Natl Cancer Inst. 84:1992;24-30.
41. Lerman C., Daly C., Sands C., Balshem A., Lustbader E., Heggan T., Goldstein L., James J., Engstrom P. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst. 85:1993;1074-1080.
42. Evans D.G., Burnell L.D., Hopwood P., Howell A. Perception of risk in women with a family history of breast cancer. Br J Cancer. 67:1993;612-614.
43. Lerman C., Lustbader E., Rimer B., Daly M., Miller S., Sands C., Balshem A. Effects of individualised breast cancer risk counselling: a randomised trial. J Natl Cancer Inst. 87:1995;286-292.
44. Lerman C., Kash K., Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being and surveillance behaviour. Monogr Natl Cancer Inst. 16:1994;171-176.
45. Evans D.G., Blair V., Greenhalgh R., Hopwood P., Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer. 70:1994;934-938.
46. Nayfield S.G., Karp J.E., Ford L.G., Dorr F.A., Kramer B.S. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst. 83:1991;1450-1459.
47. Vernon S.W., Vogel V.G., Halabi S., Bondy M.L. Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Res Treat. 28:1993;173-244.
48. Lerman C., Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat. 28:1993;144-155.
49. Hyman R.B., Baker S., Ephraim R., Moadel A., Philip J. Health belief model variables as predictors of screening mammography utilisation. J Behav Med. 17:1994;391-406.
50. Vogel V.G. High-risk populations as targets for breast cancer prevention trials. Prev Med. 20:1991;86-100.
51. Hobbs P., Smith A., George W.D., Sellwood R.A. Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J Epidemiol Commmunity Health. 34:1980;19-22.
52. Hopwood P, Evans G, Howell A. Women at high risk of breast cancer: risk perception and counselling needs. Cancer Detect Prev 1993;17:50 Abs 009/02.
53. Houlston R.S., Lemoine L., McCarter E., Harrington S., Macdermott K., Hinton J., Berger L., Slack J. Screening and genetic counselling for relatives of patients with breast cancer in the family cancer clinic. J Med Genet. 29:1992;691-694.
54. Roberts C.S., Cox C.E., Reintgen Ds., Baile W.F., Gilbertini M. Influence of physical communiation on newly diagnosed breast cancer patients. Psychologic adjustment and decision making. Cancer. 74:1994;336-344.
55. Lerman C., Daly M., Walsh W.P., Resch N., Seay J., Barsevick A., Birenbrun L., Heggan T., Martin G. Communication between patients with breast cancer and health care providers. Cancer. 72:1993;2612-2620.
56. Paraskevaidis E., Kitchener H.C., Walker L.G. Doctor-patient communication and subsequent mental health in women with gynaecological cancer. Psycho-oncology. 2:1993;195-200.
57. Girgis A., Sanson-Fisher R.W. Breaking bad news: Consensus guidelines for medical practitioners. J Clin Oncol. 13:1995;2449-2456.
58. Fallowfield L.J. Giving sad and bad news. Lancet. 341:1993;476-478.
59. Hopwood P, Howell A, Evans DG. A survey of family cancer clinic practice in the UK. Presentation at the cancer family study group meeting. Manchester, May 1994.
60. Claus E.S., Risch N., Thompson W.D. Autosomal dominant inheritance of early onset breast cancer. Cancer. 73:1994;643-651.
61. Gail M.H., Brinton L.A., Byor D.P.et al. Projecting individualised probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 81:1989;1879-1886.
62. Bondy M.L., Lustbader E.D., Halabis S., Ross E., Vogel V. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst. 86:1994;620-625.
63. Hopwood P, Long A, Keeling F, Pool C, Evans G, Howell A. Psychological support needs for women at high genetic risk of breast cancer: some useful indicators. Psycho-oncology 1996; submitted for publication.
64. Goldberg DP. Manual of the general health questionnaire. Windsor: NFER-Nelson, 1978.
65. Miller SM. When is a little knowledge a dangerous thing? Coping with stressful events by monitoring versus blunting. In: Levines, Ursin H editors. Coping and Health: proceedings ofa NATO Conference. New York: Penum Press 1980;1:45-169.
66. Schwartz M.D., Lerman C., Miller S.M., Daly M., Masny A. Coping disposition, perceived risk and psychological distress among women at increased risk for ovarian cancer. Health Psychology. 14:1995;232-235.
67. Tobacman J.K., Greene M.H., Tucker M.A.et al. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families. Lancet. 2:1982;795-797.
68. Kerr B, Hadfield L, Hopwood P, Cade D, Hoare E, Evans G. Factitious breast cancer family history: a new type of Munchausen syndrome. Lancet 1996;1034 (Letter).
69. Thirlaway K., Fallowfield L. The psychological consequences of being at risk of developing breast cancer. Eur J Cancer Prev. 2:1993;467-471.
70. Lerman C., Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med. 154:1994;609-616.